Filing Flows › Comparisons › SNY vs PFE
Sanofi vs Pfizer: SNY and PFE compared
Sanofi is the larger company: $14.4B of revenue in its latest quarter (Q3 2026) against $16.6B for Pfizer (Q3 2026). Sanofi is growing faster (+16% against -0.4% a year earlier). Sanofi is more profitable, with an operating margin of 30.1% against 20.4%.
Where the money goes: SNY and PFE
Sanofi (SNY) · Q3 2026
Sanofi, Q3 2026: revenue $14.4B (+16% year over year), operating margin 30.1%, net earnings $3.0B. The chart follows the revenue to costs, profit and cash.
Pfizer (PFE) · Q3 2026
Pfizer, Q3 2026: revenue $16.6B (-0.4% year over year), operating margin 20.4%, net earnings $3.3B, operating cash flow $5.4B. The chart follows the revenue to costs, profit and cash.
| Sanofi (SNY) | Pfizer (PFE) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $14.4B | $16.6B |
| Revenue growth, Y/Y | +16% | -0.4% |
| Gross margin | 80.3% | — |
| Operating margin | 30.1% | 20.4% |
| Net earnings | $3.0B | $3.3B |
| Net margin | 21.0% | 19.6% |
| Operating cash flow | — | $5.4B |
| Free cash flow | — | $4.8B |
| Market value | — | $169.0B |
| P/E | — | 42.0× |
| Analysts’ mean target | — | $30.11 |
Where the revenue comes from
Sanofi
- Sales at constant exchange rates: $14.2B (98%)
- Effect of exchange rates: $228M (2%)
Questions
Which is bigger, Sanofi or Pfizer?
Sanofi is the larger company: $14.4B of revenue in its latest quarter (Q3 2026) against $16.6B for Pfizer (Q3 2026).
Is Sanofi or Pfizer growing faster?
Sanofi is growing faster (+16% against -0.4% a year earlier).
Which is more profitable, Sanofi or Pfizer?
Sanofi is more profitable, with an operating margin of 30.1% against 20.4%.
More: Sanofi earnings · how Sanofi makes money · Pfizer earnings · how Pfizer makes money
From the companies' latest 10-Q, 10-K or earnings release (6-K filed Oct 30, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.